Lamivudine and Zidovudine
- Product NDC
- 68084-416
- 11-digit product format
- 680840416
- Labeler code
- 68084
- Product ID
- 68084-416_d61b8ea8-47d9-527e-e053-2a95a90aefc0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine and Zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA202418
- Marketing category
- ANDA
- Marketing start
- 2014-02-15
- Marketing end
- 2022-12-31
- Substance
- LAMIVUDINE; ZIDOVUDINE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68084-416-25 | 68084041625 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-416-25) > 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-416-95) | 30 blister pack | 2015-07-01 | 0000-00-00 | No | No | Current |